Impress has secured over €110 million in funding, led by prominent investors, to enhance its position as Europe's largest orthodontic chain and facilitate growth across the continent.

Information on the Target

Impress, currently Europe's largest orthodontic chain, has raised over €110 million in its latest funding round, significantly bolstering its position in the health tech sector. This capital influx, led by notable participants including Trinity Capital Inc., CareCapital, LBO France, and TA Ventures, underscores the confidence investors have in Impress's innovative approach to orthodontics.

The recent funding follows Impress's strategic acquisition of DrSmile from the Straumann Group, a move aimed at consolidating its market presence and enhancing its service offerings across Europe. With this financial boost, Impress is poised for robust growth, further expanding its footprint in the orthodontic market.

Industry Overview in the Target’s Specific Country

The orthodontics industry in Europe is experiencing a transformative phase, driven by advancements in technology and increasing consumer awareness. The rise in demand for aesthetic dental treatments, alongside the growing emphasis on or